|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
3-(dimethylaminomethyl)-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
9422 | abexinostat |
Synonyms ![]() |
CRA-024781 | PCI-24781 |
Database Links ![]() |
|
CAS Registry No. | 783355-60-2 |
ChEMBL Ligand | CHEMBL2103863 |
GtoPdb PubChem SID | 252166578 |
PubChem CID | 11749858 |
Search Google for chemical match using the InChIKey | MAUCONCHVWBMHK-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | MAUCONCHVWBMHK |
Search PubMed clinical trials | abexinostat |
Search PubMed titles | abexinostat |
Search PubMed titles/abstracts | abexinostat |
Search UniChem for chemical match using the InChIKey | MAUCONCHVWBMHK-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | MAUCONCHVWBMHK |
Comments |
Abexinostat is an investigational inhibitor of histone deacetylase enzymes (HDACs), with antitumour activity [1]. |